NEUROMETRIX (NASDAQ:NURO)
2.46
0.05 (1.99%)
| NEUROMETRIX (NASDAQ:NURO) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $2.51 | 52 Week High | $3.60 | ||
| Open | $2.58 | 52 Week Low | $0.52 | ||
| Day High | $2.58 | P/E | N/A | ||
| Day Low | $2.35 | EPS | $-0.61 | ||
| Volume | 40,532 | ||||
| More NURO Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| ALTI | 1 | BANR | 1 |
| DVAX | 1 | ALTI | 1 |
| BANR | 1 | HZO | 1 |
| OSIS | 1 | AXL | 1 |
| CTS | 1 | HZO | 1 |
| OSIS | 1 | AXL | 1 |
Entities who have mentioned NURO
- UBS | View Related Stories »
- Tracinda Corp. | View Related Stories »
- Kirk Kerkorian | View Related Stories »
- KeyBanc | View Related Stories »
- D.A. Davidson | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Raymond James | View Related Stories »
- Barclays | View Related Stories »
- S3 | View Related Stories »
- Credit Suisse | View Related Stories »
- Citi | View Related Stories »
- Piper Jaffray | View Related Stories »
- Goldman Sachs | View Related Stories »
- Canaccord Adams | View Related Stories »
- Deerfield Management | View Related Stories »
- Ladenburg Thalmann Financial Services | View Related Stories »
StreetInsider.com Major News for NURO
View All ReportsStreetInsider.com Reports on NURO
- NeuroMetrix (NURO) Posts Q3 Loss of $0.57, Down Y/Y
- NeuroMetrix (NURO) To Offer Up to 19M Shares
- Unusual 11 Mid-Day Movers 9/11: NURO, CMRO, ALTI, SPDE Higher; CMZ, QELP, DVAX, HZO Lower
- NeuroMetrix (NURO) Names Higgins Exec. VP, CFO
- NeuroMetrix (NURO) Announces Commitments from Institutional Investors to Buy $18.68M in Common Shares
View All Press ReleasesCompany Press Releases on NURO
- NeuroMetrix Reports Third Quarter 2009 Financial Results
- NeuroMetrix, Inc. Announces Date for 2009 Third Quarter Financial Results Conference Call
StreetInsider Reports on NURO by Category
View All BlogsBlogs on NURO
- Medical Device Trades: 7 Stocks Under 5 Bucks
- FDA Extreme Trades: 16 Stocks Under 5 Bucks
- Seven New Extreme Biotech Trades
- NeuroMetrix: Revenues Decline, Prospects Look Bleak
- NeuroMetrix: Cost Cutting and New Products Not Appeasing Investors
Comments on NURO
No comments are currently available.
